Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
BMC Vet Res ; 16(1): 108, 2020 Apr 09.
Article in English | MEDLINE | ID: mdl-32272910

ABSTRACT

BACKGROUND: Supplementation programs for prepartum beef cows are usually adopted because the nutritional status of the cows upon calving is a main factor impacting reproductive performance of the next production cycle. This study evaluated the effects of 60-d pre-partum energy-protein supplementation on performance, metabolic and hormonal responses during the peripartum phase of grazing beef cows. Thirty-eight pregnant multiparous Nellore cows were assigned to a completely randomized design with two treatments: control (no supplement) and supplementation (1.5 kg of energy-protein per d with 30% crude protein, dry matter basis). RESULTS: The supplemented cows had higher ADG pre-partum (P < 0.10), but postpartum ADG did not differ between treatments. Supplementation did not affect BCS and calf BW upon calving, on days 45 and 90, milk yield and composition (P > 0.10). No differences were found for forage intake and neutral detergent fiber digestibility (P > 0.10). The intake and digestibility of CP and OM increased in response to supplementation (P < 0.10). An interaction occurred between supplementation and peripartum days for BUN, ßHB, T3 and T4, which had higher concentrations for supplemented cows at pre-partum period (P < 0.10). Concentration of others blood parameters significantly changed along peripartum days (P < 0.10). There was no difference in pregnancy rates and days from calving to conception between treatments (P > 0.10). CONCLUSIONS: Providing an energy and protein supplement to grazing Nellore cows over the last 60 d of gestation improved their pre-partum energy balance. However, no post-partum carryover effects were detected.


Subject(s)
Animal Feed/analysis , Cattle/physiology , Diet/veterinary , Animal Nutritional Physiological Phenomena , Animals , Animals, Newborn , Brazil , Cattle/metabolism , Female , Lactation/physiology , Milk/chemistry , Peripartum Period/physiology , Pregnancy , Random Allocation , Weight Gain
2.
Med Microbiol Immunol ; 208(5): 651-666, 2019 Oct.
Article in English | MEDLINE | ID: mdl-30413884

ABSTRACT

Adipose tissue is a target of Trypanosoma cruzi infection being a parasite reservoir during the chronic phase in mice and humans. Previously, we reported that acute Trypanosoma cruzi infection in mice is linked to a severe adipose tissue loss, probably triggered by inflammation, as well as by the parasite itself. Here, we evaluated how infection affects adipose tissue homeostasis, considering adipocyte anabolic and catabolic pathways, the immune-endocrine pattern and the possible repercussion upon adipogenesis. During in vivo infection, both lipolytic and lipogenic pathways are profoundly affected, since the expression of lipolytic enzymes and lipogenic enzymes was intensely downregulated. A similar pattern was observed in isolated adipocytes from infected animals and in 3T3-L1 adipocytes infected in vitro with Trypanosoma cruzi. Moreover, 3T3-L1 adipocytes exposed to plasmas derived from infected animals also tend to downregulate lipolytic enzyme expression which was less evident regarding lipogenic enzymes. Moreover, in vivo-infected adipose tissue reveals a pro-inflammatory profile, with increased leucocyte infiltration accompanied by TNF and IL-6 overexpression, and adiponectin downregulation. Strikingly, the nuclear factor PPAR-γ is strongly decreased in adipocytes during in vivo infection. Attempts to favor PPAR-γ-mediated actions in the adipose tissue of infected animals using agonists failed, indicating that inflammation or parasite-derived factors are strongly involved in PPAR-γ inhibition. Here, we report that experimental acute Trypanosoma cruzi infection disrupts both adipocyte catabolic and anabolic metabolism secondary to PPAR-γ robust downregulation, tipping the balance towards to an adverse status compatible with the adipose tissue atrophy and the acquisition of an inflammatory phenotype.


Subject(s)
Adipose Tissue/pathology , Chagas Disease/pathology , Homeostasis , Adipocytes/parasitology , Adipocytes/pathology , Adipokines/metabolism , Animals , Cells, Cultured , Disease Models, Animal , Enzymes/metabolism , Gene Expression , Immunity, Cellular , Immunity, Humoral , Lipogenesis , Lipolysis , Mice , Trypanosoma cruzi/growth & development
3.
Neuroimmunomodulation ; 25(3): 119-128, 2018.
Article in English | MEDLINE | ID: mdl-30253402

ABSTRACT

Individuals who are infected with Trypanosoma cruzi develop chronic Chagas cardiomyopathy (CCC), which is a complication involving a series of immune pathogenetic mechanisms, although an association between immune and metabolic alterations was more recently proposed. Accordingly, we investigated the immuno-metabolic response in chagasic patients and their possible influence on CCC pathogenesis. To this end, T. cruzi-seropositive (asymptomatic or with CCC) and sero-negative individuals were studied. Serum tumour necrosis factor (TNF)-α, interleukin (IL)-6, adipocytokines and the expression of their receptors in peripheral blood mononuclear cell (PBMC) were evaluated, together with other factors influencing the immune response. CCC patients showed major metabolic and hormonal abnormalities, in parallel with increased IL-6 and leptin serum levels. TNF-α receptor s, leptin and adiponectin receptors (ObR and Adipo-Rs respectively), as well as PPAR-γ expression in PBMCs from CCC patients were compatible with a counteracting response leading to an unfavourable immune-metabolic profile. These results suggest that persistently increased levels of immune-metabolic pro-inflammatory mediators along with the adverse endocrine anti-inflammatory response of CCC individuals, may contribute to the underlying mechanisms dealing with myocardial tissue damage.


Subject(s)
Chagas Cardiomyopathy/immunology , Chagas Cardiomyopathy/metabolism , Immunity, Cellular/physiology , Metabolic Syndrome/immunology , Metabolic Syndrome/metabolism , Severity of Illness Index , Adult , Biomarkers/metabolism , Chagas Cardiomyopathy/physiopathology , Cytokines/immunology , Cytokines/metabolism , Electrocardiography/trends , Female , Humans , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Male , Metabolic Syndrome/physiopathology , Middle Aged
4.
Rev Med Inst Mex Seguro Soc ; 55(5): 579-586, 2017.
Article in Spanish | MEDLINE | ID: mdl-29193939

ABSTRACT

BACKGROUND: In several studies it has been reported a high prevalence of subclinical hypothyroidism in children with epilepsy secondary to the use of monotherapy with valproic acid, carbamazepine and phenytoin. The aim of this article is to determine the prevalence of subclinical hypothyroidism in children with drug-resistant epilepsy treated at the Pediatric Neurology Service of the Hospital de Pediatría, Centro Médico Nacional Siglo XXI in Mexico City. METHODS: We conducted a descriptive cross-sectional study. All pediatric patients with drug-resistant epilepsy and without structural alteration seen at the pediatric neurology service of our hospital between January 1 and June 1 2015 were included. Results: Prevalence of subclinical hypothyroidism in our sample was of 25%, with most patients receiving polytherapy with valproic acid. CONCLUSIONS: The intentional searching for subclinical hypothyroidism in pediatric patients with drug-resistant epilepsy without structural alteration might be considered as part of routine medical care and patients receiving combination therapy with valproic acid they should be considered as a subgroup with an increased risk of developing such comorbidity.


INTRODUCCIÓN: en diferentes estudios se ha reportado una mayor frecuencia de hipotiroidismo subclínico en niños con epilepsia secundario al uso de monoterapia con ácido valproico, carbamazepina y fenitoína. El objetivo de este estudio fue describir la frecuencia de hipotiroidismo subclínico en niños con epilepsia farmacorresistente atendidos en el Servicio de Neurología Pediátrica del Hospital de Pediatría, Centro Médico Nacional Siglo XXI. MÉTODOS: se llevó a cabo un estudio transversal descriptivo, se incluyó a todos los pacientes pediátricos con epilepsia farmacorresistente sin alteración estructural atendidos en el servicio de neurología pediátrica de nuestro hospital entre el 1 de enero y el 1 de junio de 2015. RESULTADOS: la frecuencia de hipotiroidismo subclínico en nuestra muestra fue del 25%, siendo la mayoría de los pacientes aquellos que recibían politerapia que incluía ácido valproico. CONCLUSIONES: la búsqueda de hipotiroidismo subclínico en los pacientes con epilepsia farmacorresistente sin alteración estructural podría ser considerada como parte de la atención médica habitual y aquellos pacientes que reciban politerapia con ácido valproico deben ser considerados como un subgrupo con un mayor riesgo de desarrollar dicha comorbilidad.


Subject(s)
Drug Resistant Epilepsy/complications , Hypothyroidism/epidemiology , Hypothyroidism/etiology , Adolescent , Anticonvulsants/therapeutic use , Child , Child, Preschool , Cross-Sectional Studies , Drug Resistant Epilepsy/drug therapy , Drug Therapy, Combination , Female , Humans , Hypothyroidism/diagnosis , Infant , Male , Prevalence , Retrospective Studies , Risk Factors , Valproic Acid/therapeutic use
5.
Rev Med Inst Mex Seguro Soc ; 53 Suppl 3: S228-9, 2015.
Article in Spanish | MEDLINE | ID: mdl-26509296

ABSTRACT

In the interest of encouraging the promotion of research done by physicians of the Instituto Mexicano del Seguro Social, in this supplement we publish articles written by residents of different specialties related to critical themes on pediatrics. These residents are guided by affiliated physicians from the Hospital de Pediatría del Centro Médico Nacional Siglo XXI.


Con el objetivo de fomentar la difusión de investigaciones que son producto de las tesis de los médicos del Instituto Mexicano del Seguro Social, en el presente suplemento se publican artículos escritos por residentes de diferentes especialidades relacionadas con temas prioritarios de la pediatría. Estos residentes son dirigidos por médicos adscritos del Hospital de Pediatría del Centro Médico Nacional Siglo XXI.


Subject(s)
Biomedical Research , Pediatrics , Academies and Institutes , Mexico , Periodicals as Topic , Publishing , Social Security
6.
Rev Med Inst Mex Seguro Soc ; 53 Suppl 3: S324-35, 2015.
Article in Spanish | MEDLINE | ID: mdl-26509309

ABSTRACT

BACKGROUND: Isolated ventricular septal defect (VSD) is one of the most common congenital heart diseases worldwide. Prognostic factors associated with postoperative morbidity in patients with isolated VSD in the Hospital de Pediatría del Centro Médico Nacional Siglo XXI have not been identified. METHODS: A retrospective cohort study was conducted from January 1, 2009 to December 31, 2013. Descriptive statistics and comparisons between groups were performed using chi-square test, Mann Whitney U test and linear regression. Relative risks (RR) and 95 % confidence intervals (95% CI) were calculated. RESULTS: A total of 64 patients who underwent isolated VSD closure were included, 12.5 % (n = 8) had a history of pulmonary banding and 22 patients (34.3 %) had Down syndrome. The perimembranous and subaortic lesions occurred in 70 % of cases. Factors associated with an increased morbidity and a prolonged intensive care unit (ICU) stay were: lactate at the end of extracorporeal circulation (ECC) greater than 3 mmol/L (p = 0.02) and Down syndrome (p = 0.02), who had the highest incidence of postoperative complications (p = 0.02). CONCLUSIONS: A statistically significant association was found: the higher the preoperative functional class, the longer the hospital stay, the number of days at ICU and the hours of mechanical ventilation.


Introducción: la comunicación interventricular aislada (CIV) es una de las cardiopatías congénitas más frecuentes a nivel mundial. Se desconoce cuáles son los factores pronósticos asociados a la morbilidad postoperatoria de los pacientes con CIV aislada en el Hospital de Pediatría del Centro Médico Nacional Siglo XXI. Métodos: se realizó un estudio de cohorte retrospectivo del 1 de enero de 2009 al 31 de diciembre de 2013. Se utilizó estadística descriptiva y comparaciones entre los grupos mediante chi cuadrada, U de Mann Whitney y regresión lineal. Se calcularon riesgos relativos (RR) e intervalos de confianza al 95 % (IC 95%). Resultados: se incluyeron 64 pacientes a quienes se les realizó cierre de comunicación interventricular aislada. El 12.5 % (n = 8) tenían antecedente de cerclaje pulmonar y 22 (34.3 %) pacientes tenían síndrome de Down. Las CIV perimembranosas y la subaórtica se presentaron en 70 % de los casos. Los factores asociados a una mayor morbilidad y estancia prolongada en terapia intensiva fueron: lactato al final de la circulación extracorpórea (CEC) mayor a 3mmol/L (p = 0.02) y el síndrome de Down (p = 0.02) quienes presentaron una mayor frecuencia de complicaciones postoperatorias (p = 0.02). Conclusiones: se encontró una asociación estadísticamente significativa: cuanto mayor era la clase funcional preoperatoria, mayor era su estancia intrahospitalaria, con mayor número de días en terapia intensiva y mayor tiempo de ventilación mecánica asistida.


Subject(s)
Heart Septal Defects, Ventricular/surgery , Postoperative Complications/etiology , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Linear Models , Male , Postoperative Complications/diagnosis , Postoperative Complications/epidemiology , Prognosis , Retrospective Studies , Risk Factors
7.
Cir Cir ; 83(3): 217-21, 2015.
Article in Spanish | MEDLINE | ID: mdl-26055282

ABSTRACT

BACKGROUND: Gastric non-Hodgkin lymphoma is a rare tumour that represents approximately 7% of all stomach cancers and 2% of all lymphomas. The most frequent location of gastric MALT (mucosa associated lymphoid tissue) lymphomas is in the antrum in 41% of the cases, and 33% can be multifocal. The risk of spontaneous perforation of a gastric MALT lymphoma is 4-10%. CLINICAL CASE: 24 year old male patient carrying the Human Immunodeficiency Virus, who began with signs and symptoms of acute abdomen and fever 72 hours before arriving in the emergency room. A computed tomography was performed that showed free fluid in the cavity, and gastric wall thickening. The patient underwent a laparotomy, finding absence of the anterior wall of the stomach, sealed with the left lobe of the liver, colon and omentum. Total gastrectomy, with oesophagosty and jejunostomy tube, was performed. CONCLUSIONS: Gastric perforation secondary to a MALT lymphoma is rare, with high mortality. There is limited information reported of this complication and should be highly suspected in order to provide appropriate treatment for a complication of this type.


Subject(s)
Lymphoma, B-Cell, Marginal Zone/complications , Stomach Neoplasms/complications , Stomach Rupture/etiology , Humans , Male , Young Adult
8.
Univ. med ; 51(1): 86-93, ene.-mar. 2010. ilus
Article in Spanish | LILACS | ID: lil-601542

ABSTRACT

La deficiencia del factor VII es una enfermedad hemorrágica rara, causada por la disminución o ausencia de este factor de la coagulación; menos de 200 casos se han reportado desde que se describió por primera vez en 1951. Es un trastorno autonómico recesivo que puede afectar a varios miembros de una familia. Su prevalencia es de 1:500.000 (0,5% de todos los trastornos hereditarios de la coagulación) y su distribución es igual entre los sexos. El defecto está localizado en el cromosoma 13q34. Sólo los individuos homocigotos o heterocigotos compuestos, es decir, que son portadores de dos mutaciones diferentes, presentan manifestaciones hemorrágicas. Los heterocigotos son asintomáticos. El déficit puede ser cualitativo o cuantitativo. La forma de presentación clínica es variable y la seriedad de las hemorragias no guarda relación directa con los niveles de factor VII o su actividad. El cuadro clínico puede ser muy grave y se puede presentar hemorragia intracerebral temprana, hemartrosis o manifestaciones moderadas, dadas por sangrado mucocutáneo o hemorragia tras una intervención quirúrgica; algunos casos pueden cursar asintomáticos, a pesar de valores muy bajos de factor VII. El diagnóstico se hace mediante pruebas de coagulación, al encontrar un tiempo de protrombina prolongado con un tiempo parcial de tromboplastina normal y con la posterior cuantificación de factor VII disminuido (valores normales de 70 a 130%).


Factor VII deficiency is a rare hemorrhagic disease caused by the decrease or absence of this coagulation factor; no more than 200 cases have been reported since it was first discovered in 1951. It is an autosomal recessive disorder, which may affect several members of a family. Its prevalence is 1:500,000 (0.5% of all hereditary disorders of coagulation) and its distribution is the same in both genders. The defect is located on chromosome 13q34. Only homozygous or compound heterozygous individuals have different hemorrhagic manifestations. The heterozygotes are asymptomatic. The deficit may be qualitative or quantitative. The clinical manifestations are variable and the severity of bleeding is not directly related to factor VII titers or its activity. The clinical picture may be very severe, patients could present with an early intracerebral hemorrhage, hemarthrosis or moderate findings, given by mucocutaneous bleeding or bleeding after surgery, moreover in some cases it may be asymptomatic despite very low values of factor VII. The diagnosis is made by coagulation tests to find a prolonged prothrombin time with a normal PTT and the subsequent quantification of factor VII decreased (VN 70-130%).


Subject(s)
Hematologic Diseases , Bone Diseases , Kidney Diseases
9.
Bol. méd. Hosp. Infant. Méx ; 63(3): 162-168, may.-jun. 2006. tab
Article in Spanish | LILACS | ID: lil-700817

ABSTRACT

Introducción. El objetivo de este estudio fue determinar los niveles séricos de colesterol y lipoproteinas en un grupo de adolescentes de la Ciudad de México. Material y métodos. Se determinaron niveles séricos de lípidos en un grupo de adolescentes. Se aplicó un cuestionario sobre antecedentes familiares de infarto agudo al miocardio, hipercolesterolemia o diabetes mellitus. Para el análisis estadístico se usó SPSS Y EPI DAT.V3. Resultados. Se estudió a 413 adolescentes, hombres y mujeres, con una edad promedio de 13 años, 14% tenían antecedentes familiares de hipercolesterolemia, 5% de infarto al miocardio y 24.7% de obesidad. El grupo presentó los siguientes valores promedio: colesterol 161 ± 36 mg/dL, triglicéridos 103.9 ± 63 mg/dL, LDL 91.6 ± 58 mg/dL, VLDL 32.3 ± 64 mg/dL y HDL 25.34 mg/dL, sin diferencia significativa entre ambos sexos; 259 (62%) adolescentes presentaron colesterol normal, 102 (24.6%) tuvieron niveles limítrofes altos y 52 (12.6%) hipercolesterolemia. Conclusión. Los niveles de lípidos encontrados muestran un incremento de 10% en el promedio de colesterol, 30% más en la frecuencia de colesterol limítrofe alto y 40% más de hipercolesterolemia en relación a lo reportado en estudios de los últimos 10 años.


Introduction. To know the cholesterol and lipoprotein levels in an adolescents group in Mexico City. Material and methods. We applied a questionnaire about family history of: myocardial infarction, hypercholesterolemia and diabetes mellitus. Cholesterol and lipoproteins measurement were performed in a group of adolescents. SPSS and EPID AT. V3 were used for statistics. Results. Four hundred thirty adolescents were studied, the mean age were 13 years old. We found 14% hypercholesterolemic family history, 5% coronary disease and 24.7% obesity. The mean lipid levels were: cholesterol 161.3 ± 36 mg/dL, triglycerides 103 ± 63 mg/dL, low density lipoprotein 91.6 ± 58 mg/dL, very low density lipoprotein 32.4 ± 64 mg/dL and high density lipoprotein 25.34 mg/dL, there were not difference between male and female; 259 (62%) adolescents presented normal cholesterol levels, 102 (24.6%) high borderline levels and 52 (12.6%) had hypercholesterolemia. Conclusion. The main cholesterol level found was 10% higher, frequency of high borderline cholesterol levels was 30% more and hypercholesterolemia frequency increase 40% in relation to previous reports.

10.
Rev. invest. clín ; 52(5): 509-16, sept.-oct. 2000. tab, graf, CD-ROM
Article in Spanish | LILACS | ID: lil-294973

ABSTRACT

Objetivo. Investigar si los cambios en la actividad de la triptófano-5-hidroxilasa y la síntesis de serotonina cerebral provocados por diabetes mellitus, persisten o regresan a lo normal en el animal diabético tratado con insulina. Metodología. Se usaron ratas diabéticas por la administración de estreptozotocina y ratas diabéticas tratadas con insulina. A los días 7, 14 y 21 de evolución, se pesaron y se les determinó en el cerebro: la actividad de la triptófano-5-hidroxilasa y las concentraciones de L-triptófano y serotonina. En el plasma se les midió glucosa, albúmina y L-triptófano. Resultados. Los diabéticos mostraron un déficit significativo de peso corporal. El mismo patrón se observó en la albúmina y en el L-triptófano plasmático. En la corteza cerebral se observó que el L-triptófano, la 5-hidroxitriptamina y la actividad de la enzima fueron significativamente menores. Además, la actividad de la enzima en el tallo cerebral fue mayor, acompañada de una elevación de la 5-hidroxitriptamina. Los animales diabéticos tratados con insulina tuvieron una recuperación física y un retorno a lo normal del L-triptófano en el cerebro y en la sangre. Sin embargo, la actividad de la triptófano-5-hidroxilasa permaneció elevada a pesar del tratamiento con insulina y persistió un aumento de la síntesis del neurotransmisor tanto en el tallo como en la corteza cerebral. Conclusión. Los resultados confirman que la diabetes mellitus produce desnutrición crónica y una disminución en la síntesis de serotonina en el cerebro. Además, apoyan que el tratamiento con insulina en los diabéticos produce una recuperación física y un regreso a lo normal del precursor de la serotonina el L-triptófano plasmático y cerebral, pero interesantemente, a pesar de este hecho, la actividad de la triptófano-5-hidroxilasa permaneció elevada acompañada de un aumento del neurotransmisor. Estos hallazgos en conjunto, sugieren que el mecanismo de activación de la biosíntesis de la serotonina cerebral puede ser debido a un cambio relacionado a la cinética de la triptófano-5-hidroxilasa, más que a los cambios de la concentración plasmática y cerebral del L-triptófano inducidos por la diabetes mellitus. Esta alteración en el metabolismo de un neurotransmisor puede participar en los mecanismos fisiopatológicos de las alteraciones neuropsicológicas en los enfermos diabéticos.


Subject(s)
Animals , Rats , Diabetes Mellitus, Experimental , Insulin/therapeutic use , Serotonin/biosynthesis , Diabetes Mellitus/physiopathology , Tryptophan Hydroxylase/pharmacokinetics
11.
Rev. invest. clín ; 51(5): 293-302, sept.-oct. 1999. tab, graf
Article in Spanish | LILACS | ID: lil-259003

ABSTRACT

Objetivo. Determinar si las ratas con diabetes mellitus insulino-dependiente tienen una menor actividad de la vía serotoninérgica a través de la medición de la fracción libre del L-triptófano plasmático. Metodología. Se utilizó el modelo de la administración de estreptozotocina en ratas para el desarrollo de diabetes mellitus insulino-dependiente. A los 7, 14 y 21 días se les determinó la actividad de la vía serotoninérgica. Resultados. El grupo diabético mostró disminución del peso corporal y del nivel de L-triptófano (libre, unido y total) en el plasma. En el tejido nervioso también se presentó disminución del nivel de L-triptófano, de la serotonina y de la actividad de la triptófano-5-hidroxilasa. Por el contrario, la actividad de la hidroxilasa estuvo alta en el tallo cerebral desde el día 14, acompañada de una elevación de la síntesis de serotonina. Conclusiones. Se confirma que la diabetes mellitus insulino-dependiente produce una desnutrición crónica. La baja de L-triptófano en la sangre sugiere que su ingreso al cerebro está disminuido y que hay una menor síntesis del neurotransmisor, tal como se demostró en el cerebro de estos animales diabéticos. Sin embargo, el hecho de que la actividad de la triptófano-5-hidroxilasa se eleva en el tallo cerebral, con un consecuente aumento de la síntesis de serotonina, nos permite plantear que existe cambio en la síntesis del neurotransmisor dependiendo de la región, con las consecuencias funcionales respectivas


Subject(s)
Animals , Male , Rats , Diabetes Mellitus, Type 1/metabolism , Rats, Wistar/blood , Serotonin/biosynthesis , Tryptophan Hydroxylase/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...